Negative chemotaxis

pathway activity — cross-omics
GO:0050919Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative chemotaxis pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ERMN, DACT3, and CDKL5, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative chemotaxis activity versus ERMN in GBM (Pearson r = 0.40).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMERMN →+1.548+0.612<.001<.00134
BRCADACT3 →+0.743+0.936<.001<.00134
GBMCDKL5 →+0.536+0.605.001.00134
BRCAIRAG1 →+0.886+0.771<.001<.00134
LSCCPRICKLE2 →+0.501+0.434<.001<.00134
BRCAGREM2 →+0.807+0.776<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0050919 vs ERMN — GBM

Per-sample scatter of Negative chemotaxis activity vs ERMN in GBM.

Explore this scatter interactively →

Exploration